1231. In Vitro Activity of Aztreonam-Avibactam and Comparator Agents Against Enterobacterales from Patients with Lower Respiratory Tract Infections Collected During the ATLAS Global Surveillance Program, 2017-2019

BACKGROUND: β-lactamase-producing Enterobacterales (Ebact) frequently co-carry resistance to antimicrobials from other classes, limiting treatment options. Avibactam (AVI) inhibits class A, class C, and some class D serine β-lactamases, while aztreonam (ATM) is refractory to hydrolysis by class B me...

Descripción completa

Detalles Bibliográficos
Autores principales: Lob, Sibylle, Kazmierczak, Krystyna, Arhin, Francis, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643937/
http://dx.doi.org/10.1093/ofid/ofab466.1423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643937/
http://dx.doi.org/10.1093/ofid/ofab466.1423

Ejemplares similares